Vaccine Thimerosal Reduction Plans To Be Discussed At Public Meeting
Executive Summary
Concrete plans and a realistic timeframe for vaccine manufacturers to eliminate or reduce thimerosal from their products will be discussed at a public workshop between manufacturers, Public Health Service agencies and the American Academy of Pediatrics.